A team of international researchers led by Karolinska Institutet has revealed in unprecedented detail how tetracycline antibiotics impair T cell function by binding mitochondrial ribosomes and ...
Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of antibiotics for serious and life-threatening bacterial ...
A new open-access review proposes attacking both the upstream enzymes of the bacterial shikimate pathway and the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results